Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Net revenue:
Total net revenue	[1]	$ 97,459	$ 98,826	$ 182,791	$ 188,403
Cost of revenue:
Total cost of revenue	[2]	56,628	60,926	106,557	117,560
Gross profit		40,831	37,900	76,234	70,843
Operating expenses:
Research and development	[3]	11,956	13,064	24,104	26,405
Selling and marketing		10,348	11,327	19,246	24,593
General and administrative		10,328	9,886	19,217	20,502
Total operating expenses		32,632	34,277	62,567	71,500
Income (loss) from operations		8,199	3,623	13,667	(657)
Income on equity method investment, net		1,117		1,089
Other (expense) income, net		(4,260)	7,766	(8,954)	3,327
Income before provision for income taxes		5,056	11,389	5,802	2,670
Provision for income taxes		287	679	631	1,316
Net income		$ 4,769	$ 10,710	$ 5,171	$ 1,354
Net income per share - basic		$ 0.05	$ 0.12	$ 0.06	$ 0.02
Net income per share - diluted		$ 0.05	$ 0.12	$ 0.06	$ 0.02
Weighted average common shares used in computing net income per share:
Basic		92,025	89,517	91,609	89,145
Diluted		93,353	90,279	92,607	90,095
Net income		$ 4,769	$ 10,710	$ 5,171	$ 1,354
Foreign currency translation adjustment		1,809	877	3,302	(141)
Comprehensive income		6,578	11,587	8,473	1,213
Products
Net revenue:
Total net revenue		41,805	43,760	73,063	81,365
Cost of revenue:
Total cost of revenue		23,102	24,518	41,528	46,088
Services
Net revenue:
Total net revenue		55,654	55,066	109,728	107,038
Cost of revenue:
Total cost of revenue		$ 33,526	$ 36,408	$ 65,029	$ 71,472

[1] Includes sales to the China joint venture, an equity method investment of $4,632 and $9,583 for the three and six months ended December 31, 2020 and $2,643 and $6,460 for the three and six months ended December 31, 2019, respectively. See Note 14.

[2] Includes cost of revenue from sales to the China joint venture, an equity method investment of $2,757 and $4,701 for the three and six months ended December 31, 2020, respectively, and of $2,140 and $4,631 for the three and six months ended December 31, 2019, respectively.

[3] Includes chargeback to the China joint venture, an equity method investment related to research and development project of $430 for the three and six months ended   December 31, 2020, respectively, and no chargeback for the three and six months ended December 31, 2019.